{"viewingHint":"paged","service":[{"profile":"http://iiif.io/api/search/1/search","@context":"http://iiif.io/api/search/1/context.json","@id":"https://noah.nrw/i3f/manifest/4290103/search","label":"Search within this manifest"}],"structures":[],"sequences":[{"canvases":[{"height":2339,"width":1654,"images":[{"resource":{"service":{"profile":"http://iiif.io/api/image/2/level2.json","@context":"http://iiif.io/api/image/2/context.json","@id":"https://noah.nrw/i3f/v20/4818080"},"format":"image/jpeg","height":1414,"width":1000,"@id":"https://noah.nrw/download/webcache/1000/4818080","@type":"dctypes:Image"},"on":"https://noah.nrw/i3f/v20/4290103/canvas/4818080","motivation":"sc:painting","@id":"https://noah.nrw/i3f/v20/4290103/annotation/4818080","@type":"oa:Annotation"}],"label":"[1]","@id":"https://noah.nrw/i3f/v20/4290103/canvas/4818080","@type":"sc:Canvas"},{"height":2339,"width":1654,"images":[{"resource":{"service":{"profile":"http://iiif.io/api/image/2/level2.json","@context":"http://iiif.io/api/image/2/context.json","@id":"https://noah.nrw/i3f/v20/4818081"},"format":"image/jpeg","height":1414,"width":1000,"@id":"https://noah.nrw/download/webcache/1000/4818081","@type":"dctypes:Image"},"on":"https://noah.nrw/i3f/v20/4290103/canvas/4818081","motivation":"sc:painting","@id":"https://noah.nrw/i3f/v20/4290103/annotation/4818081","@type":"oa:Annotation"}],"label":"[2]","@id":"https://noah.nrw/i3f/v20/4290103/canvas/4818081","@type":"sc:Canvas"}],"viewingHint":"paged","startCanvas":"https://noah.nrw/i3f/v20/4290103/canvas/4818080","viewingDirection":"left-to-right","label":"Current Page Order","@context":"http://iiif.io/api/presentation/2/context.json","@id":"https://noah.nrw/i3f/v20/4290103/sequence/normal","@type":"sc:Sequence"}],"label":"Mergers & acquisitions (M&A) in the pharmaceutical industry","thumbnail":{"width":304,"height":429,"@id":"https://noah.nrw/i3f/v21/4818080/full/304/0/default.jpg","@type":"dctypes:Image","format":"image/jpeg"},"logo":{"@id":"https://noah.nrw/domainresource/static/graphics/connectors/viewerLogo.gif","service":{"profile":"http://iiif.io/api/image/2/level2.json","@context":"http://iiif.io/api/image/2/context.json","@id":""}},"@context":"http://iiif.io/api/presentation/2/context.json","seeAlso":{"format":"application/xml","@id":"https://noah.nrw/oai?verb=GetRecord&metadataPrefix=mets&identifier=4290103","label":"METS"},"@id":"https://noah.nrw/i3f/v20/4290103/manifest","@type":"sc:Manifest","metadata":[{"value":"Mergers & acquisitions (M&A) in the pharmaceutical industry : the wheel keeps on turning","label":"Titel"},{"value":"Mandewirth, Sven Oliver","label":"Verfasser"},{"value":"Hornke, Matthias","label":"Verfasser"},{"value":"Journal of Business Chemistry, H. Journal of Business Chemistry, S. 67-68","label":"Enthalten in"},{"value":"2010","label":"Erschienen"},{"value":"Section \"Commentary\"","label":"Anmerkung"},{"value":"Englisch","label":"Sprache"},{"value":"Aufsatz in einer Zeitschrift","label":"Dokumenttyp"},{"value":"urn:nbn:de:hbz:6-57479535991","label":"URN"}]}